LDDD
Price
$5.02
Change
+$0.02 (+0.40%)
Updated
Dec 17 closing price
MCRPF
Price
$0.83
Change
+$0.07 (+9.21%)
Updated
Dec 17 closing price
Ad is loading...

LDDD vs MCRPF

Header iconLDDD vs MCRPF Comparison
Open Charts LDDD vs MCRPFBanner chart's image
LONGDUODUO
Price$5.02
Change+$0.02 (+0.40%)
Volume$107
CapitalizationN/A
Microport Scientific
Price$0.83
Change+$0.07 (+9.21%)
Volume$10K
CapitalizationN/A
LDDD vs MCRPF Comparison Chart
Loading...
View a ticker or compare two or three
VS
LDDD vs. MCRPF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LDDD is a Hold and MCRPF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (LDDD: $5.02 vs. MCRPF: $0.83)
Brand notoriety: LDDD and MCRPF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LDDD: 62% vs. MCRPF: 22%
Market capitalization -- LDDD: $1.88B vs. MCRPF: $3.66B
LDDD [@Medical Specialties] is valued at $1.88B. MCRPF’s [@Medical Specialties] market capitalization is $3.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LDDD’s FA Score shows that 0 FA rating(s) are green whileMCRPF’s FA Score has 1 green FA rating(s).

  • LDDD’s FA Score: 0 green, 5 red.
  • MCRPF’s FA Score: 1 green, 4 red.
According to our system of comparison, MCRPF is a better buy in the long-term than LDDD.

Price Growth

LDDD (@Medical Specialties) experienced а -10.36% price change this week, while MCRPF (@Medical Specialties) price change was +8.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.22%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +1.33%.

Industries' Descriptions

@Medical Specialties (-4.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
MCRPF($3.66B) has a higher market cap than LDDD($1.88B). MCRPF YTD gains are higher at: -18.227 vs. LDDD (-26.393). LDDD has higher annual earnings (EBITDA): -1.09M vs. MCRPF (-201.14M). MCRPF has more cash in the bank: 1.75B vs. LDDD (645K). LDDD has less debt than MCRPF: LDDD (14.1K) vs MCRPF (1.24B). MCRPF has higher revenues than LDDD: MCRPF (779M) vs LDDD (1.6M).
LDDDMCRPFLDDD / MCRPF
Capitalization1.88B3.66B51%
EBITDA-1.09M-201.14M1%
Gain YTD-26.393-18.227145%
P/E RatioN/AN/A-
Revenue1.6M779M0%
Total Cash645K1.75B0%
Total Debt14.1K1.24B0%
FUNDAMENTALS RATINGS
MCRPF: Fundamental Ratings
MCRPF
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

LDDD and

Correlation & Price change

A.I.dvisor tells us that LDDD and BDSX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LDDD and BDSX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LDDD
1D Price
Change %
LDDD100%
+0.40%
BDSX - LDDD
22%
Poorly correlated
+1.46%
MCRPF - LDDD
22%
Poorly correlated
+8.91%
INBS - LDDD
20%
Poorly correlated
-7.07%
ZJYL - LDDD
15%
Poorly correlated
-8.30%
HSCS - LDDD
10%
Poorly correlated
N/A
More

MCRPF and

Correlation & Price change

A.I.dvisor tells us that MCRPF and LDDD have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCRPF and LDDD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRPF
1D Price
Change %
MCRPF100%
+8.91%
LDDD - MCRPF
21%
Poorly correlated
+0.40%
NUMD - MCRPF
6%
Poorly correlated
-6.67%
NHNKF - MCRPF
1%
Poorly correlated
N/A
NNCSF - MCRPF
1%
Poorly correlated
N/A
MRCHF - MCRPF
-0%
Poorly correlated
N/A
More